Uzbekistan cuts prices for nearly 6,500 drugs: outcomes of regulation and remaining problems
Abdulla Azizov, director of the Pharmaceutical Industry Development Agency, explained how drug price revisions proceeded: certain medicines became 40–60% cheaper. He also noted a reduction in the number of pharma agents, a rise in prescriptions for dietary supplements, and the incomplete rollout of electronic prescriptions.
Otabek Yusupov